A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients

被引：0
|
作者：
Jose Francis
Biswajit Dubashi
Rajan Sundaram
Suresh Chandra Pradhan
Adithan Chandrasekaran
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Pharmacology
[2] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Medical Oncology
[3] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Clinical Pharmacology
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Imatinib; Thrombocytopenia; Therapeutic drug monitoring; Pharmacogenetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1189
页数：4
相关论文
共 13 条
  • [1] A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients
    Francis, Jose
    Dubashi, Biswajit
    Sundaram, Rajan
    Pradhan, Suresh Chandra
    Chandrasekaran, Adithan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1185 - 1189
  • [2] Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients
    Au, Anthony
    Baba, Abdul Aziz
    Goh, Ai Sim
    Fadilah, S. Abdul Wahid
    Teh, Alan
    Rosline, Hassan
    Ankathil, Ravindran
    BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (03) : 343 - 349
  • [3] Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
    Loscocco, Federica
    Visani, Giuseppe
    Ruzzo, Annamaria
    Bagaloni, Irene
    Fuligni, Fabio
    Galimberti, Sara
    Di Paolo, Antonello
    Stagno, Fabio
    Pregno, Patrizia
    Annunziata, Mario
    Gozzini, Antonella
    Barulli, Sara
    Gabucci, Elisa
    Magnani, Mauro
    Isidori, Alessandro
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [4] A Study to Explore the Role of IDH1 (R132) Mutation on Imatinib Toxicity and Effect of ABCG2/OCT1 Expression on N-Desmethyl Imatinib Plasma Level in Egyptian Chronic Myeloid Leukemia Patients
    Sabri, Alaa
    Omran, Mervat M. M.
    Azim, S. Abdel
    Abdelfattah, Raafat
    Allam, Rasha Mahmoud
    Shouman, Samia A. A.
    DRUG RESEARCH, 2023, 73 (03) : 146 - 155
  • [5] Polymorphisms of ABCG2, ABCB1 and HNF4α are associated with Lamotrigine trough concentrations in epilepsy patients
    Zhou, Yafang
    Wang, Xueding
    Li, Hongliang
    Zhang, Jie
    Chen, Ziyi
    Xie, Wen
    Zhang, Jinxin
    Li, Jiali
    Zhou, Liemin
    Huang, Min
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (04) : 282 - 287
  • [6] Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients
    Nouri, Negar
    Mehrzad, Valiollah
    Khalaj, Zahra
    Zaker, Erfan
    Zare, Fateme
    Abbasi, Elham
    Khosravi, Maede
    Kalantar, Seyed Mehdi
    Salehi, Mansoor
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2023, 24 (01)
  • [7] Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients
    Negar Nouri
    Valiollah Mehrzad
    Zahra Khalaj
    Erfan Zaker
    Fateme Zare
    Elham Abbasi
    Maede Khosravi
    Seyed Mehdi Kalantar
    Mansoor Salehi
    Egyptian Journal of Medical Human Genetics, 24
  • [8] Association of Genetic Polymorphisms in the Influx Transporter SLCO1B3 and the Efflux Transporter ABCB1 With Imatinib Pharmacokinetics in Patients With Chronic Myeloid Leukemia
    Yamakawa, Yuji
    Hamada, Akinobu
    Nakashima, Reiko
    Yuki, Misato
    Hirayama, Chie
    Kawaguchi, Tatsuya
    Saito, Hideyuki
    THERAPEUTIC DRUG MONITORING, 2011, 33 (02) : 244 - 250
  • [9] Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia
    Madejczyk, Anna Marta
    Canzian, Federico
    Gora-Tybor, Joanna
    Campa, Daniele
    Sacha, Tomasz
    Link-Lenczowska, Dorota
    Florek, Izabela
    Prejzner, Witold
    Calbecka, M.
    Rymko, M.
    Dudzinski, M.
    Orzechowska, Magdalena Julita
    Jamroziak, Krzysztof
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia
    Mangoura, Safwat A.
    Abdel-Raheem, Mahmoud H.
    Eltyb, Hanan A.
    Molla, Mohammed S.
    Hussein, Abeer M. R.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
12